Frontlight ResearchEarly access
CompletedPhase 4
Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2
Key facts
- Who runs it
- Pontificia Universidad Catolica de Chile
- Where
- Spain23 sites in 1 countryChoose a country to see its sites
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 500 people enrolled
- Started
- 27 May 2022
- Ended
- 28 Jul 2025
- Type of study
- Interventional
- Record updated
- 23 January 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Consecutive adult patients (≥ 18 years) with septic shock according to Sepsis-3 consensus conference. In short, septic shock is defined as suspected or confirmed infection, plus hyperlactatemia and NE requirements due to persistent hypotension, after a fluid load of at least 1000mL in 1h
Who cannot take part
- More than 4 hours since septic shock diagnosis - Anticipated surgery or acute hemodialysis procedure to start during the 6h intervention period - Active bleeding, - Do not resuscitate status, - Child B-C Cirrhosis - Underlying disease process with a life expectancy < 90 days and/or the attending clinician deems aggressive resuscitation unsuitable - Refractory shock (high risk of death within 24h) - Pregnancy - Concomitant severe acute respiratory distress syndrome. - Patients in whom CRT cannot be accurately assessed
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To test if a CRT-targeted resuscitation based on clinical hemodynamic phenotyping can improve a hierarchical clinical outcome - mortality, time to cessation of vital support, and length of hospital stay, all within 28 days - in septic shock patients as compared to usual care.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov and on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Publications
- Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial.JAMA, 2025
- Doppler identified venous congestion in septic shock: protocol for an international, multi-centre prospective cohort study (Andromeda-VEXUS).BMJ open, 2023
- Hemodynamic phenotype-based, capillary refill time-targeted resuscitation in early septic shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial study protocol.Revista Brasileira de terapia intensiva, 2022
- Record updated
- 23 January 2025